HK Stock MarketDetailed Quotes
01498 PURAPHARM
- 0.730
- +0.040+5.80%
Not Open Oct 4 16:08 CST
289.01MMarket Cap-3318P/E (TTM)
0.730High0.690Low464.00KVolume0.700Open0.690Pre Close328.80KTurnover0.12%Turnover RatioLossP/E (Static)395.90MShares1.13052wk High2.21P/B289.01MFloat Cap0.63052wk Low--Dividend TTM395.90MShs Float4.127Historical High--Dividend LFY5.80%Amplitude0.560Historical Low0.708Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
PURAPHARM Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6.43%207.63M | -9.20%406.86M | -15.46%195.08M | -32.07%448.07M | -23.78%230.76M | 9.60%659.59M | 7.96%302.76M | -13.52%601.82M | -15.93%280.43M | -6.66%695.88M |
| Operating income | 6.43%207.63M | -9.20%406.86M | -15.46%195.08M | -32.07%448.07M | -23.78%230.76M | 9.60%659.59M | 7.96%302.76M | -13.52%601.82M | -15.93%280.43M | -6.66%695.88M |
| Cost of sales | -13.48%-94.37M | -2.62%-190.23M | -3.10%-83.16M | 21.53%-185.37M | 24.16%-80.66M | -1.89%-236.24M | 8.00%-106.35M | 21.94%-231.87M | 17.50%-115.6M | -2.22%-297.04M |
| Operating expenses | -13.48%-94.37M | -2.62%-190.23M | -3.10%-83.16M | 21.53%-185.37M | 24.16%-80.66M | -1.89%-236.24M | 8.00%-106.35M | 21.94%-231.87M | 17.50%-115.6M | -2.22%-297.04M |
| Gross profit | 1.19%113.26M | -17.54%216.63M | -25.44%111.93M | -37.95%262.7M | -23.57%150.11M | 14.44%423.35M | 19.15%196.4M | -7.24%369.95M | -14.79%164.83M | -12.32%398.84M |
| Selling expenses | 19.87%-40.2M | 41.76%-91.66M | 39.08%-50.17M | 28.46%-157.38M | 10.91%-82.36M | -4.50%-220.01M | 4.48%-92.44M | 6.93%-210.54M | 16.47%-96.78M | 1.64%-226.21M |
| Administrative expenses | 6.08%-75.71M | -8.62%-171.52M | -0.75%-80.61M | 6.25%-157.92M | 2.77%-80.01M | -9.77%-168.45M | -8.73%-82.29M | 32.84%-153.46M | 28.41%-75.68M | -5.28%-228.48M |
| Impairment and provision | 2,847.83%1.26M | -39.92%-20.89M | -102.23%-46K | 82.36%-14.93M | 163.96%2.06M | -665.14%-84.62M | 13.74%-3.22M | 90.31%-11.06M | -38.81%-3.73M | ---114.18M |
| -Impairment of property, machinery and equipment | ---- | -323.69%-12.8M | ---- | ---3.02M | ---- | ---- | ---- | 98.80%-229K | ---- | ---19.06M |
| -Goodwill impairment | ---- | ---3.05M | ---- | ---- | ---- | ---67.35M | ---- | ---- | ---- | ---67.35M |
| -Other impairment is provision | 2,847.83%1.26M | 57.72%-5.03M | -102.23%-46K | 31.09%-11.91M | 163.96%2.06M | -59.52%-17.28M | 13.74%-3.22M | 61.00%-10.83M | -38.81%-3.73M | ---27.77M |
| Special items of operating profit | 100.52%22K | 73.34%-7.32M | 59.40%-4.27M | 32.05%-27.48M | -184.56%-10.51M | -156.04%-40.44M | -68.07%12.43M | 481.52%72.15M | 2,370.35%38.91M | -146.66%-18.91M |
| Operating profit | 94.11%-1.36M | 21.30%-74.76M | -11.89%-23.17M | -5.36%-95M | -167.05%-20.71M | -234.48%-90.17M | 12.07%30.88M | 135.48%67.05M | 194.26%27.55M | -490.31%-188.95M |
| Financing cost | 0.72%-13.25M | -13.33%-27.41M | 4.62%-13.35M | 10.52%-24.18M | -3.72%-13.99M | -0.73%-27.03M | -20.84%-13.49M | 1.37%-26.83M | 17.39%-11.17M | -24.33%-27.2M |
| Share of profit from joint venture company | ---149K | ---145K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 59.56%-14.77M | 14.15%-102.31M | -5.23%-36.51M | -1.70%-119.18M | -299.58%-34.7M | -391.40%-117.19M | 6.09%17.39M | 118.61%40.22M | 138.34%16.39M | -914.71%-216.15M |
| Tax | -237.73%-3.92M | -265.21%-3.77M | 77.69%-1.16M | 77.97%-1.03M | 3.84%-5.2M | 44.93%-4.69M | -9.31%-5.41M | 23.42%-8.51M | -103.58%-4.95M | -94.03%-11.11M |
| After-tax profit from continuing operations | 50.40%-18.69M | 11.76%-106.08M | 5.58%-37.68M | 1.36%-120.21M | -433.25%-39.9M | -484.35%-121.88M | 4.70%11.97M | 113.95%31.71M | 125.31%11.44M | -1,192.27%-227.26M |
| Earning after tax | 50.40%-18.69M | 11.76%-106.08M | 5.58%-37.68M | 1.36%-120.21M | -433.25%-39.9M | -484.35%-121.88M | 4.70%11.97M | 113.95%31.71M | 125.31%11.44M | -1,192.27%-227.26M |
| Profit attributable to shareholders | 50.40%-18.69M | 11.76%-106.08M | 5.58%-37.68M | 1.36%-120.21M | -433.25%-39.9M | -484.35%-121.88M | 4.70%11.97M | 113.95%31.71M | 125.31%11.44M | -1,192.27%-227.26M |
| Basic earnings per share | 50.42%-0.0473 | 11.88%-0.2685 | 5.73%-0.0954 | 1.55%-0.3047 | -432.89%-0.1012 | -461.99%-0.3095 | -7.32%0.0304 | 109.81%0.0855 | 118.53%0.0328 | -1,168.14%-0.8716 |
| Diluted earnings per share | 50.42%-0.0473 | 11.88%-0.2685 | 5.73%-0.0954 | 1.55%-0.3047 | -432.89%-0.1012 | -462.41%-0.3095 | -7.32%0.0304 | 109.80%0.0854 | 118.53%0.0328 | -1,174.72%-0.8716 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data